Friday October 3, 2008 (foodconsumer.org) -- Researchers at the University of Wisconsin-Madison might
have found a key target that can be used to prevent overeating, obesity or
treat diseases related to obesity.
Reported in the Oct. 3, 2008 issue of Cell, Dr. Dongsheng
Cai at the UW School of Medicine and Public Health said there is a messaging
system in the brain that controls food intake and body weight.
Cai and colleagues found at the hypothalamus in the brain
a cell-signaling pathway that is known to be associated with inflammation
affects the regulation of food intake.
When the pathway is stimulated, animals like humans
increase their energy consumption when suppressed they maintain normal food
intake and body weight.
Obesity, which is caused by overeating, is commonly
associated with a range of diseases such as heart disease and type 2 diabetes,
which is most commonly found in developed countries where food is so cheap and
so delicious that people can’t help, but eat more than what they need.
Cai's research was meant to provide some explanation how
food and energy consumption affects metabolic inflammation, which is associated
with an array of metabolic disorders.
Early studies at Harvard led by Cai and colleagues
already found a compound known as IKKbeta activates a protein complex called
NF-kappaB, inducing inflammatory reaction in many cells.
The pathway that can be activated by high-sugar and
high-fat diet interrupts sugar, fat, or protein metabolism in tissues like
liver, fat and skeletal muscle.
In the current study of mice, Cai and colleagues found for
the first time that the pathway involving IKKbeta/NF-kappaB also exists in
specific neurons in the hypothalamus, but is normally inactive.
They found that over-nutrition by overeating high-fat
diet activated the pathway, specifically in neurons in the hypothalamus.
When NF-kappaB activity was suppressed for example by knocking
out the IKKbeta gene and thus eliminating the production of IKKbeta, the mice
were significantly protected from energy over consumption and obesity
development.
This suggests that a drug that can suppress IKKbeta gene
may be used to prevent overeating and or obesity.
Cai and his term also found a cell component called the
endoplasmic reticulum (ER), shown recently to be involved in metabolic diseases
involving over-nutrition can also play a role in over-nutrition activating
IKKbeta/NF-kappaB in the hypothalamus.
Over-nutrition led to ER stress which forced activation
of NF-kappaB, promoting increased food intake and obesity development, the study
found.
"The ultimate goal will certainly be to identify a
selective and effective suppressor of the pathway to target related
neurons," Cai said.
Disclaimer: What's published on this website should be considered opinions of respective writers only and foodconsumer.org which has no political agenda nor commercial ambition may or may not endorse any opinion of any writer. No accuracy is guaranteed although writers are doing their best to provide accurate information only.
The information on this website should not be construed as medical advice and should not be used to replace professional services provided by qualified or licensed health care workers. The site serves only as a platform for writers and readers to share knowledge, experience, and information from the scientific community, organizations, government agencies and individuals.
Foodconsumer.org encourages readers who have had medical conditions to consult with licensed health care providers - conventional and or alternative medical practitioners.